MDLZ — Mondelez International, Inc.

The market is leaning bullish: consensus rating is Buy (32 buy / 8 hold / 2 sell), the average analyst price target is $70.29, and Q2 2026 adjusted EPS of $0.73 beat by $0.05 on revenue of $9.36B, up 4.1% YoY. Management also raised the quarterly dividend 4% to $0.52 and returned roughly $1.5B to shareholders in H1 2026. The price action itself is not stretched — RSI 49 and a 0.7% move below the 20-day — so the bullishness is fundamentals/catalyst-driven rather than momentum-driven.

Reported revenue is growing, but organic growth is modest: Q2 2026 revenue rose 4.1% YoY to $9.36B, with organic growth of only 2.2% and volume/mix adding just 0.7%. Q1 2026 reported growth was stronger at +8.2%, so the second quarter is a step down. Geographically, emerging markets remain the growth engine at +4.4% organic, while Europe contracted 3.5% — a widening divergence. GAAP margins are noisy because of one-off items: Q2 2026 operating margin printed 20.8% and net income was $1.55B, but TTM operating margin is 11.4% and net margin is 8.9%, roughly 1 point below the year-ago TTM operating margin. TTM free cash flow is about $3.1B. The picture is a slow-growth, margin-squeezed staple with a mild positive inflection, not a structural acceleration.

At $62.43, the stock is cheaper than its own history: TTM P/E is 22.95x versus the 5-year average of 24.25x, and P/S is 2.01x versus 2.58x. Forward P/E is roughly 20.5x on next-FY consensus EPS of $3.05. That is not optically cheap, but it is a reasonable multiple for a defensive consumer staple with a 3.46% dividend yield and stable cash flow. The GAAP PEG ratio of -15.8 is meaningless because trailing EPS is distorted by one-off items; using forward growth, the valuation looks fair rather than expensive.

The stock is neither pricing in a major growth acceleration nor pricing in a collapse. At roughly 20.5x forward earnings, you are paying a fair defensive multiple for mid-single-digit EPS growth, a 3.5% yield, and buybacks. Upside toward the $70 consensus target would require cocoa costs to ease, Europe volumes to stabilize, and continued capital returns. Downside is cushioned by the dividend yield and a multiple already below its 5-year average. This is a “fair price for steady compounding” setup, not a momentum trade.

As of 2026-08-27, RSI(14) was 49.16 — neutral, not overbought or oversold. Price was 0.7% below the 20-day SMA, 1.69% above the 50-day SMA, and 5.91% above the 200-day SMA, so the medium-term trend is still up but momentum has stalled. With the stock at $62.43, near the upper half of its 52-week range, this is not an oversold entry point; the better risk/reward would be on a pullback toward the 50-day or lower-$60s support.

• Cocoa price inflation and volatility continue to pressure chocolate margins; pricing and hedging are only partial offsets.
• Interest rates and Treasury yields: the 3.46% dividend yield becomes less attractive if rates stay high, and consumer-staple multiples remain rate-sensitive.
• Consumer spending divergence: U.S. and Europe are showing cost-of-living-driven volume softness, while emerging markets are still growing volumes and trade-up demand.
• Foreign exchange: a stronger dollar would reduce reported revenue from Mondelez’s large international and emerging-market footprint; a weaker dollar helps.

• Barclays Global Consumer Staples Conference on September 9, 2026, where COO Luca Zaramella and CFO Amit Banati may provide updated margin and H2 volume commentary.
• Q3 2026 earnings expected around October 27, 2026 — key watch items are Europe volume recovery, organic growth maintenance, and holiday-season cocoa cost commentary.
• Potential cocoa price normalization and continued pricing actions that restore gross margin toward historical levels.
• Continued dividend and buyback execution; the 4% dividend raise and $1.5B returned in H1 2026 support EPS and total return.

• Cocoa prices stay elevated or rise further, compressing chocolate margins despite pricing and hedging.
• Europe remains a drag: organic revenue fell 3.5% in Q2, and market-share challenges could persist.
• Leverage and liquidity: debt-to-equity is 0.83 and the current ratio is 0.60, which is common for staples but leaves limited flexibility if rates stay high.
• Consumer trade-down in the U.S. and Europe if cost-of-living pressures intensify, pressuring volumes and premium products.

Mondelez is a high-quality defensive cash generator with iconic brands, a 3.46% dividend yield, and a valuation below its own 5-year average. But growth is modest, Europe is weak, and cocoa is a live margin threat. I see it as fairly valued rather than a bargain or a short; it is a reasonable core holding to accumulate on weakness, but not a compelling buy at $62.43.

I applied a 21.5x forward P/E multiple to next-FY consensus EPS of $3.05, a discount to Mondelez’s 5-year average P/E of 24.25x and a slight premium to its current 20.5x forward P/E, reflecting stable defensive cash flow and dividend support while acknowledging cocoa margin pressure and weak Europe. This yields a fair value of $65.53, below the $70.29 analyst consensus but above the $62.43 current price.